Since December 2019, the SARS-CoV-2 (COVID-19) pandemic has transfixed the medical
world. COVID-19 symptoms vary from mild to severe and underlying chronic conditions such …

It is hypothesized that several comorbidities increase the severity of COVID‑19 symptoms.
Cardiovascular disease including hypertension was shown to play a critical role in the …

The global action against coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2
infection, shed light on endothelial dysfunction. Although SARS-CoV-2 primarily affects the …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2), has been recently considered a systemic disorder leading to …

Objective: Whether endotheliopathy only mirrors coronavirus disease 2019 (COVID-19)
severity or plays an intrinsic role in microvascular thrombosis and organ failure remains …

Abstract Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary
complications such as acute myocardial injury, renal failure or thromboembolic events. A …

The global propagation of SARS-CoV-2 leads to an unprecedented public health
emergency. Despite that the lungs are the primary organ targeted by COVID-19, systemic …

COVID‑19 patients with severe infection have been observed to have elevated auto‑
antibodies (AAs) against angiotensin II receptor type 1 (AT1R) and endothelin (ET) 1 …

Abstract SARS-CoV-2, the virus that causes coronavirus disease 19 (COVID-19), is
associated with a bewildering array of cardiovascular manifestations, including myocardial …

Patients with COVID-19 present a wide spectrum of disease severity, from asymptomatic
cases in the majority to serious disease leading to critical care and even death. Clinically …